Neoadjuvant immunotherapy improves outcomes in high-risk melanoma patients.

Published Date: 02 Mar 2023

High-risk melanoma patients who received the drug pembrolizumab before or after surgery to remove the cancer had a higher risk of developing melanoma than those who did not have a similar condition that eliminated cancer cells.

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Pressing the Sleep button could have a positive impact on cognition.

2.

The Higher the Disability Burden From Disease, the Higher the Suicide Risk

3.

Nivolumab Regimen Achieves Durable PFS in Advanced Hodgkin's Lymphoma

4.

Including Isatuximab with a Standard Backbone Enhances Multiple Myeloma Results.

5.

A Cancer Patient's Cats Inspired a Push for Pets in Hospice Wards


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot